1 – 15 of 54
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Previous SARS-CoV-2 infections and their impact on the protection from reinfection during the Omicron BA.5 wave – a nested case-control study among vaccinated adults in Sweden
(
- Contribution to journal › Article
-
Mark
Population scale proteomics enables adaptive digital twin modelling in sepsis
2024)(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Performance of the 2023 Duke-ISCVID diagnostic criteria for infective endocarditis in relation to the modified Duke criteria and to clinical management- reanalysis of retrospective bacteremia cohorts
(
- Contribution to journal › Article
-
Mark
Gut microbiota composition is altered in postural orthostatic tachycardia syndrome and post-acute COVID-19 syndrome
(
- Contribution to journal › Article
- 2023
-
Mark
Waning protection after vaccination and prior infection against COVID-19-related mortality over 18 months
(
- Contribution to journal › Article
-
Mark
Qdenga® - A promising dengue fever vaccine; can it be recommended to non-immune travelers?
(
- Contribution to journal › Article
-
Mark
Antiviral tablettbehandling av covid-19 – ett värdefullt tillskott
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Synovial monocytes contribute to chronic inflammation in childhood-onset arthritis via IL-6/STAT signalling and cell-cell interactions
(
- Contribution to journal › Article
-
Mark
Primary diphtheria immunisation of adolescents and adults with low-dose vaccine, a survey of historic evidence from the literature
(
- Contribution to journal › Article
-
Mark
Identification of novel autoantigens as potential biomarkers in juvenile idiopathic arthritis associated uveitis
(
- Contribution to journal › Article
- 2022
-
Mark
Blood culture time to positivity in non-β-hemolytic streptococcal bacteremia as a predictor of infective endocarditis-a retrospective cohort study
(
- Contribution to journal › Article
-
Mark
High level of protection against COVID-19 after two doses of BNT162b2 vaccine in the working age population–first results from a cohort study in Southern Sweden
(
- Contribution to journal › Article
-
Mark
Ascorbic acid attenuates activation and cytokine production in sepsis-like monocytes
(
- Contribution to journal › Article
-
Mark
The Dynamics of Circulating Heparin-Binding Protein : Implications for Its Use as a Biomarker
(
- Contribution to journal › Article
-
Mark
COVID-19 vaccine effectiveness against severe disease from SARS-CoV-2 Omicron BA.1 and BA.2 subvariants - surveillance results from southern Sweden, December 2021 to March 2022
2022) In Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 27(18).(
- Contribution to journal › Article